GLP-1s: Lilly, Novo Gallop In India, Generic Firms Gear ‘To Finish The Race’

 
• By Anju Ghangurde
  
GLP-1s
Experts discuss huge untapped opportunities for GLP-1s in markets like India (Shutterstock)

More from India

More from Scrip